Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial (PCL/TCP)
Primary Purpose
Fractures, Enophthalmos, Diplopia
Status
Unknown status
Phase
Phase 2
Locations
Singapore
Study Type
Interventional
Intervention
Polycaprolactone / Tri-Calcium Phosphate
Titanium Mesh
Sponsored by
About this trial
This is an interventional treatment trial for Fractures focused on measuring Orbital, fractures, enophthalmos, diplopia, eye
Eligibility Criteria
Inclusion Criteria:
- age 21 y - 70 y
- both males / females included
- orbital fractures
- defect after orbital osteotomies
Exclusion Criteria:
- patient refusal
- infection around the orbit / generalised infection
- Diabetes mellitus
- allergies to polycaprolactone & its analogues
- allergies to titanium
Sites / Locations
- National University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Polycaprolactone / Tricalcium Phosphate
Control
Arm Description
Polycaprolactone / Tricalcium Phosphate group to assess efficacy of new implant
Control group with titanium mesh
Outcomes
Primary Outcome Measures
Enophthalmos
Assess the presence of enophthalmos after reconstruction of the orbital walls at 1 week, 1 month, 3 months, 6 months and 12 months
Secondary Outcome Measures
Diplopia
Assess the evidence of diplopia on follow up at 1 week, 1 month, 3 months, 6 months and 12 months
motility of the globe
assess globe motility on follow up at 1 week, 1 month, 3 months, 6 months, and 12 months
Full Information
NCT ID
NCT01119144
First Posted
May 5, 2010
Last Updated
April 24, 2014
Sponsor
National University Hospital, Singapore
1. Study Identification
Unique Protocol Identification Number
NCT01119144
Brief Title
Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial
Acronym
PCL/TCP
Official Title
Comparing the Reconstruction of the Orbit Fracture With a Poly Caprolactone / Tri-Calcium Phosphate ( PCL/TCP ) Implant vs. a Titanium Mesh Implant.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2014
Overall Recruitment Status
Unknown status
Study Start Date
April 2010 (undefined)
Primary Completion Date
March 2015 (Anticipated)
Study Completion Date
March 2015 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
National University Hospital, Singapore
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Hypothesis: Polycaprolactone / Tricalcium Phosphate Orbital (PCL / TCP) Implant is as effective in the reconstruction of the Orbital walls as Titanium Mesh implant.
In this study we will be conducting a randomised trial to compare implants made of 2 materials for Orbital reconstruction
Polycaprolactone / Tricalcium Phosphate (PCL / TCP)
Titanium
Patients to be recruited :
80 randomised equally into the 2 groups
age range: 21 - 70
includes orbital wall defects from trauma, after osteotomies
excludes patients with Diabetes Mellitus, known allergies to polycaprolactone & its analogues, know allergies to Tricalcium Phosphate & its analogues, infections generalised & around the orbital region
Trial Duration: April 2010 - March 2015
Follow up:
postoperative 1 week, 1 month, 3 months, 6 months, and 12 months
Computer Tomographic (CT) scan of Orbits immediate postoperative and at 12 months appointment
Detailed Description
Hypothesis: Polycaprolactone / Tricalcium Phosphate (PCL / TCP) Orbital Implant is as effective in the reconstruction of the Orbital walls as Titanium Mesh
In this study we will be conducting a randomised trial to compare implants made of 2 materials for Orbital reconstruction
Polycaprolactone / Tricalcium Phosphate (PCL / TCP)
Titanium
Patients to be recruited :
80 randomised equally into the 2 groups
age range: 21 -70
includes orbital wall defects from trauma confirmed by Computer Tomographic (CT) scans, after osteotomies
excludes patients with Diabetes Mellitus, known allergies to polycaprolactone & its analogues, know allergies to Tricalcium Phosphate & its analogues, infections generalised & around the orbital region
Trial Duration : April 2010 - March 2015
Follow up:
postoperative 1 week, 1 month, 3 months, 6 months, and 12 months
Computer Tomographic (CT) scan of Orbits immediate postoperative and at 12 months appointment
all patients will be seen & assessed in the Plastic & Ophthalmology outpatient clinics by Principal Investigator (PI) and collaborators
End point :
endpoint for follow-up is 12 months
all patients are assessed for assessed for diplopia, enophthalmos, exophthalmos, visual acuity, mobility of the globe, contour symmetry
all patients will have a Computer Tomographic (CT) scan of the orbits at 12 months to assess the bony orbit & orbital volume
patients will be discharged from follow up at 12 months if asymptomatic
patients with complications will exit the protocol & will be treated on their merits eg. infection - removal of implant, etc
Data Management :
maintained by the Principal Investigator (PI) under repository of the Research & Development Office, National Healthcare Group (NHG) / National University Health Systems (NUHS), Singapore
no data will be released without the permission of the Principal Investigator (PI) & the Research & Development Office, National Healthcare Group (NHG) / National University Health Systems (NUHS), Singapore
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fractures, Enophthalmos, Diplopia
Keywords
Orbital, fractures, enophthalmos, diplopia, eye
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Polycaprolactone / Tricalcium Phosphate
Arm Type
Experimental
Arm Description
Polycaprolactone / Tricalcium Phosphate group to assess efficacy of new implant
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Control group with titanium mesh
Intervention Type
Device
Intervention Name(s)
Polycaprolactone / Tri-Calcium Phosphate
Other Intervention Name(s)
Osteomesh Tri-Calcium Phosphate (TCP)
Intervention Description
Orbital implant for reconstruction of the orbital walls
Intervention Type
Device
Intervention Name(s)
Titanium Mesh
Other Intervention Name(s)
Titanium Orbital mesh
Intervention Description
Titanium mesh for comparison to Polycaprolactone / Tri-Calcium Phosphate (PCL / TCP) mesh
Primary Outcome Measure Information:
Title
Enophthalmos
Description
Assess the presence of enophthalmos after reconstruction of the orbital walls at 1 week, 1 month, 3 months, 6 months and 12 months
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Diplopia
Description
Assess the evidence of diplopia on follow up at 1 week, 1 month, 3 months, 6 months and 12 months
Time Frame
1 year
Title
motility of the globe
Description
assess globe motility on follow up at 1 week, 1 month, 3 months, 6 months, and 12 months
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age 21 y - 70 y
both males / females included
orbital fractures
defect after orbital osteotomies
Exclusion Criteria:
patient refusal
infection around the orbit / generalised infection
Diabetes mellitus
allergies to polycaprolactone & its analogues
allergies to titanium
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thiam Chye Lim, MD
Organizational Affiliation
Natioanl University Hospital, Singapore
Official's Role
Principal Investigator
Facility Information:
Facility Name
National University Hospital
City
Singapore
ZIP/Postal Code
119074
Country
Singapore
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thiam Chye Lim
Email
surlimtc@nus.edu.sg
First Name & Middle Initial & Last Name & Degree
Eileen Hing
Email
surhch@nus.edu.sg
First Name & Middle Initial & Last Name & Degree
Thiam Chye Lim, FRCS
12. IPD Sharing Statement
Learn more about this trial
Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial
We'll reach out to this number within 24 hrs